Abstract:OBJECTIVE:To separate the cell subpopulation with high tumorigenic ability and study the biological characteristics of this subpopulation in laryngeal carcinoma cells.METHODS:Human laryngeal carcinoma cells were obtained by primary tissue culture technique. CD44 and CD133 molecules were used as markers to isolate the CD44(+), CD133(+), CD44(+)CD133(+) and CD44(+)CD133(-) cell subpopulations from the laryngeal carcinoma cells by flow cytometry. A nude mouse tumor xenograft model was developed for the study of the tumorigenic effects of the different cell populations. 1 x 10(6), 1 x 10(5), 1 x 10(4) and 1 x 10(3) cells were injected into the left flank of the mice, respectively. The mice were observed for palpable tumor formation and were sacrificed at 4 weeks later to assess the tumor formation rate, tumor volume and tumor weight. Boyden chamber migration assay was used to determine the migration ability and immunochemistry was used to detect the expression of stem cell antigen SCA-1 and beta1-integrin. Semi-quantities RT-PCR and Western blot analysis were performed to detect the expression level of Bmi-1 in the different cell subpopulations.RESULTS:The growth of subcutaneous tumors in nude mice showed that a tumor can be generated with 1 x 10(3) CD44(+)CD133(+) cells. When the same dose of 1 x 10(6) CD44(+)CD133(+) cells was injected into the mice, both the average weight and volume of the tumors were significantly higher than those generated from other cell subpopulations. Boyden chamber migration assay showed that the invasion ability of CD44(+)CD133(+) cells was significantly higher than that of other cell subsets. The results of immunochemical analysis showed an abundant expression of stem cell antigen SCA-1 and beta1-integrin in the CD44(+)CD133(+) cells. Semi-quantitative RT-PCR and Western blot analysis provided strong evidence that the Bmi-1 expression in CD44(+)CD133(+) and CD133(+) cells was very significantly higher than that in CD44(+), CD44(+)CD133(-) and control cells (P < 0.01).CONCLUSION:Our findings demonstrate that CD44(+)CD133(+) subset cells in laryngeal carcinoma posses some biological characteristics of tumor stem cells, which may be the original cells of laryngeal carcinoma and may become a new target of tumor therapy.

Biological Characteristics of a Cell Subpopulation in Tongue Squamous Cell Carcinoma.

[Biological Characteristics of CD133+ Subpopulation in Tongue Squamous Cell Carcinoma Tca8113 Cell Line].

Role of CD133+ Cells in Tongue Squamous Carcinomas: Characteristics of ‘stemness’ in Vivo and in Vitro

Identification and Characterization of CD133(pos) Subpopulation Cells from a Human Laryngeal Cancer Cell Line.

[Isolation and in Vitro Characterization of CD133(+) Side Population Cells from Laryngeal Cancer Cell Line].

[Isolation and in Vivo Tumorigenicity Assay of CD133+ Side Population Cells from Laryngeal Cancer Cell Line].

[Biological Characteristics of Highly Tumorigenic CD44+CD133+ Subpopulation of Laryngeal Carcinoma Cells].

Quantitative Analyses of CD133 Expression Facilitate Researches on Tumor Stem Cells.

Tumor-Infiltrating CD1a + DCs and CD8 + /FoxP3 + Ratios Served as Predictors for Clinical Outcomes in Tongue Squamous Cell Carcinoma Patients

Correlation of ALDH1, CD44, OCT4 and SOX2 in Tongue Squamous Cell Carcinoma and Their Association with Disease Progression and Prognosis.

Single-cell profiling of tumor-infiltrating TCF1/TCF7+ T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer

P75 Neurotrophin Receptor: A Potential Surface Marker of Tongue Squamous Cell Carcinoma Stem Cells

CD103+ T and Dendritic Cells Indicate a Favorable Prognosis in Oral Cancer.

Genome-wide Gene Expression Profiling of Tongue Squamous Cell Carcinoma by RNA-seq

In Vitro Induction of Dendritic Cell from Peripheral Blood of Patients with Tongue Squamous Cell Carcinoma

An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma

[Differential Proteomics Research on Exosomes Derived from Tongue Squamous Cell Carcinoma Cells and Normal Mucosa Cells].

Identification of differentially expressed genes in oral squamous cell carcinoma TCA8113 cells.

The relationship between the expression of CD44v3 or CD44v6 in tongue squamous cell carcinoma and the prognosis

CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome

Isolation and Characterization of Cancer Stem-Like Cells from MHCC97H Cell Lines